Chemical Component Summary | |
---|---|
Name | Zebularine |
Identifiers | 1-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]pyrimidin-2-one |
Formula | C9 H12 N2 O5 |
Molecular Weight | 228.202 |
Type | NON-POLYMER |
Isomeric SMILES | C1=CN(C(=O)N=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O |
InChI | InChI=1S/C9H12N2O5/c12-4-5-6(13)7(14)8(16-5)11-3-1-2-10-9(11)15/h1-3,5-8,12-14H,4H2/t5-,6-,7-,8-/m1/s1 |
InChIKey | RPQZTTQVRYEKCR-WCTZXXKLSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 28 |
Chiral Atom Count | 4 |
Bond Count | 29 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB03068? |
---|---|
Name | Zebularine |
Groups | experimental |
Description | A chemically stable, cytidine analog that displays anti-tumor properties. It acts as a transition state analog inhibitor of cytidine deaminase by binding to the active site as covalent hydrates. Also shown to inhibit DNA methylation and tumor growth both in vitro and in vivo. |
Synonyms |
|
Categories |
|
CAS number | 3690-10-6 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Cytidine deaminase | MHPRFQTAFAQLADNLQSALEPILADKYFPALLTGEQVSSLKSATGLDED... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 100016 |
ChEMBL | CHEMBL504567 |
ChEBI | CHEBI:46938 |